Clinical trial
The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal…
NCT00324974 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00324974 |
|---|---|
| Title | The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux |
| Official title | A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Study Assessing the Safety and Efficacy of Lansoprazole Microgranules Oral Suspension in Infants With Symptomatic Gastroesophageal Reflux |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | Lansoprazole microgranules suspension, Placebo |
| Enrollment | 162 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | May 11, 2006 |
| Last update posted | Jul 22, 2010 |
| Countries | Poland, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: